Iris Energy Limited vs Tenet Healthcare Corporation — how do they compare? Iris Energy Limited trades at $36.95 (market cap $15.25B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Tenet Healthcare Corporation is the larger of the two by market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Iris Energy Limited nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iris Energy Limited for 28 Days and Tenet Healthcare Corporation for 15 Days on average.
| IREN | THC | |
|---|---|---|
Market Cap | $15.25B | $20.92B |
Volume | 51,114,233 | 455,764 |
Sector | Technology | Health |
52-Week High | $76.41 | $280.77 |
52-Week Low | $29.31 | $161.37 |
Typical Hold Time | 28 Days | 15 Days |
Enterprise Value | $17.19B | $32.00B |
Signals from Pluang's Aura AI — not financial advice
IREN trades at $38.69, down 6.27% amid bearish technical signals despite strong analyst support with 12 buy ratings and an $81 consensus target. The stock faces fundamental challenges with negative net income margin (-99.38%) and ROE (-23.41%) despite 2025 revenue of $501M. Recent news highlights the company's pivot from Bitcoin mining to AI infrastructure with major contracts including a $9.7B Microsoft deal, though execution risks and capital intensity concerns weigh on sentiment.
The outlook remains bifurcated with Wall Street optimism for long-term AI infrastructure growth potential conflicting with near-term profitability challenges. Key opportunities include the 5GW+ power pipeline and hyperscaler partnerships, while risks center on execution of massive spending plans, competitive pressures, and the sustainability of current valuation multiples given negative earnings trends.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Iris Energy is a next-generation data center company that powers Bitcoin mining and AI workloads using 100% renewable energy. It focuses on building sustainable infrastructure for the global digital economy.
Read more on IREN →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →